Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence

References

• FernandezHChabbert-BuffetNKoskasMNazacAEpidemiological data for uterine fibroids in France in 2010–2012 in medical center – analysis from the French DRG-based information system (PMSI)J Gynecol Obstet Biol Reprod (Paris)2014438616628 French25017711
   PubMedGoogle Scholar
• FernandezHChabbert BuffetNAlloucheSPrevalence of uterine fibroids in France and impact on quality of life: results of a survey among 2500 women between 30–55 yearsJ Gynecol Obstet Biol Reprod (Paris)2014439721727 French25124196
   PubMedGoogle Scholar
• DonnezJJadoulPWhat are the implications of myomas on fertility? A need for a debate?Hum Reprod20021761424143012042254
   PubMed Web of Science ®Google Scholar
• MarretHFritelXOuldamerLCNGOF (French College of Gynecology and Obstetrics)Therapeutic management of uterine fibroid tumors: updated French guidelinesEur J Obstet Gynecol Reprod Biol2012165215616422939241
   PubMed Web of Science ®Google Scholar
• LethabyAVollenhovenBSowterMEfficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic reviewBJOG2002109101097110812387461
   PubMed Web of Science ®Google Scholar
• BroekmansFJGnRH agonists and uterine leiomyomasHum Reprod199611Suppl 33259147098
   PubMed Web of Science ®Google Scholar
• NisolleMGillerotSCasanas-RouxFSquiffletJBerliereMDonnezJImmunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapyHum Reprod199914112844285010548634
   PubMed Web of Science ®Google Scholar
• KimJJSeftonECThe role of progesterone signaling in the pathogenesis of uterine leiomyomaMol Cell Endocrinol2012358222323121672608
   PubMed Web of Science ®Google Scholar
• DonnezJTatarchukTFBouchardPPEARL I Study GroupUlipristal acetate versus placebo for fibroid treatment before surgeryN Engl J Med2012366540942022296075
   PubMed Web of Science ®Google Scholar
• DonnezJTomaszewskiJVázquezFPEARL II Study GroupUlipristal acetate versus leuprolide acetate for uterine fibroidsN Engl J Med2012366542143222296076
   PubMed Web of Science ®Google Scholar
• KoskasMChabbert-BuffetNDouvierSHuchonCPaganelliEDerrienJRole of medical treatment for symptomatic leiomyoma management in premenopausal womenJ Gynecol Obstet Biol Reprod (Paris)2011408858874 French22071015
   PubMedGoogle Scholar
• KeLQYangKLiJLiCMDanazol for uterine fibroids [review]Cochrane Database Syst Rev20093CD00769219588442
   PubMed Web of Science ®Google Scholar
• GrigorievaVChen-MokMTarasovaMMikhailovAUse of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomasFertil Steril20037951194119812738516
   PubMed Web of Science ®Google Scholar
• Murat NakiMTekcanCOzcanNCebiMLevonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumesFertil Steril201094137137419896649
   PubMed Web of Science ®Google Scholar
• RizkallaHFHigginsMKelehanPO’HerlihyCPathological findings associated with the presence of a mirena intrauterine system at hysterectomyInt J Gynecol Pathol2008271747818156979
   PubMed Web of Science ®Google Scholar
• OrtmannODiedrichKPituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analoguesHum Reprod199914Suppl 119420610573034
   PubMed Web of Science ®Google Scholar
• TamayaTFujimotoJOkadaHComparison of cellular levels of steroid receptors in uterine leiomyoma and myometriumActa Obstet Gynecol Scand19856443073094024879
   PubMed Web of Science ®Google Scholar
• MaruoTMatsuoHShimomuraYEffects of progesterone on growth factor expression in human uterine leiomyomaSteroids20036810–1381782414667973
   PubMed Web of Science ®Google Scholar
• Chabbert-BuffetNMeduriGBouchardPSpitzIMSelective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applicationsHum Reprod Update200511329330715790602
   PubMed Web of Science ®Google Scholar
• ChwaliszKPerezMCDemannoDWinkelCSchubertGElgerWSelective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosisEndocr Rev200526342343815857972
   PubMed Web of Science ®Google Scholar
• DonnezJVázquezFTomaszewskiJPEARL III and PEARL III Extension Study GroupLong-term treatment of uterine fibroids with ulipristal acetateFertil Steril201410161565157324630081
   PubMed Web of Science ®Google Scholar
• DonnezJHudecekRDonnezOEfficacy and safety of repeated use of ulipristal acetate in uterine fibroidsFertil Steril2015103251952725542821
   PubMed Web of Science ®Google Scholar
• WilliamsARBergeronCBarlowDHFerenczyAEndometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetateInt J Gynecol Pathol201231655656923018219
   PubMed Web of Science ®Google Scholar
• BonneauCPerrinMKoskasMGeninASRouzierREpidemiology and risk factors for cancer of the uterusRev Prat2014646774779 French25090759
   PubMedGoogle Scholar
• LuyckxMSquiffletJLJadoulPVotinoRDolmansMMDonnezJFirst series of 18 pregnancies after ulipristal acetate treatment for uterine fibroidsFertil Steril201410251404140925241376
   PubMed Web of Science ®Google Scholar
• GoldbergJPereiraLPregnancy outcomes following treatment for fibroids: uterine fibroid embolization versus laparoscopic myomectomyCurr Opin Obstet Gynecol200618440240616794420
   PubMed Web of Science ®Google Scholar
• UzanJKoskasMFournierPMarguliesALLutonDYazbeckCColouterine fistula after polymyomectomy: a case reportJ Med Case Rep2014819924942344
   PubMedGoogle Scholar
• European Medicines AgencyScience Medicines Health [homepage on the Internet] Available from: http://www.ema.europa.eu/emaAccessed January 21, 2015
   Google Scholar
• PolattiF1ViazzoFColleoniRNappiREUterine myoma in post-menopause: a comparison between two therapeutic schedules of HRTMaturitas2000371273211099870
   PubMed Web of Science ®Google Scholar